本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Neumora Therapeutics, Inc.

0.7798
+0.01281.67%
盤前0.7510-0.0288-3.69%08:01 EDT
成交量:80.47萬
成交額:61.38萬
市值:1.26億
市盈率:-0.51
高:0.7798
開:0.7630
低:0.7315
收:0.7670
資料載入中...
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/15

重要事件披露

Form 8-K - Current report
2024/03/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/07

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

重要事件披露

Form 8-K - Current report